Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Precision Biosciences Inc (NQ: DTIL )

0.7397 -0.0508 (-6.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 690,524
Open 0.7900
Bid (Size) 0.7401 (5)
Ask (Size) 0.8248 (10)
Prev. Close 0.7905
Today's Range 0.7150 - 0.8248
52wk Range 0.7807 - 3.640
Shares Outstanding 111,295,723
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's morning session saw 84 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
 
Via Benzinga

Performance

YTD
-36.78%
-36.78%
1 Month
-36.23%
-36.23%
3 Month
-30.22%
-30.22%
6 Month
-45.61%
-45.61%
1 Year
-77.85%
-77.85%

More News

Read More
Looking Into Precision BioSciences's Return On Capital Employed
Via Benzinga
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
From Precision BioSciences, Inc.
Via Business Wire
Preview: Precision BioSciences's Earnings
Via Benzinga
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2022 Results on March 9, 2023
From Precision BioSciences, Inc.
Via Business Wire
Precision BioSciences Announces Senior Leadership Promotions and Organizational Changes
From Precision BioSciences, Inc.
Via Business Wire
Precision BioSciences Earnings Perspective: Return On Capital Employed
Via Benzinga
Precision BioSciences to Participate in Upcoming H.C. Wainwright Cell Therapy Virtual Conference
From Precision BioSciences, Inc.
Via Business Wire
There's a Lot of Upside For Emerging Gene-Editing Companies
Via MarketBeat
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Precision BioSciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Precision BioSciences Recaps 2022 Accomplishments and Outlines 2023 Corporate Priorities and Planned Portfolio Milestones
From Precision BioSciences
Via Business Wire
Precision BioSciences Receives Favorable Type C Feedback from the FDA on the Company’s Chemistry, Manufacturing, and Controls (CMC) Strategies for Late-Stage Development of Azercabtagene Zapreleucel, its Lead Allogeneic CAR T Clinical Candidate
From Precision BioSciences, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Precision BioSciences Presents Analysis of Azer-Cel, Allogeneic CAR T Product Attributes Related to In Vivo Pharmacokinetics, Pharmacodynamics, and Clinical Outcomes at 2022 American Society of Hematology Annual Meeting
From Precision BioSciences, Inc.
Via Business Wire
Precision BioSciences Announces Change to its Board of Directors
From Precision BioSciences, Inc.
Via Business Wire
Coinbase To $80? Plus Deutsche Bank Cuts PT On This Stock By 80%
Via Benzinga
Precision BioSciences Reports Third Quarter 2022 Financial Results and Provides Business Update
From Precision BioSciences, Inc.
Via Business Wire
Precision BioSciences's Earnings Outlook
Via Benzinga
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Precision BioSciences, Inc.
Via Business Wire
Precision BioSciences Announces Data Presentation on Effective Cell Dose and Functional Attributes of CD19 Allogeneic CAR T, Azer-Cel, at the Upcoming 2022 American Society of Hematology (ASH) Annual Meeting
From Precision BioSciences, Inc.
Via Business Wire
Precision BioSciences to Report Third Quarter 2022 Financial Results on November 8, 2022
From Precision BioSciences, Inc.
Via Business Wire
Precision BioSciences Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
From Precision BioSciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.